Back to peptides

LL-37

Cathelicidin antimicrobial peptide

Key facts

Primary use

Antimicrobial / immune

Evidence

Preclinical

Typical dose ranges

100-1000 mcg/day

Half-life

Short

Routes

subcutaneous
Long-form page in progress
The catalog summary above is what we have here. Mechanism, protocols, evidence detail, and safety notes are on the roadmap. Browse the full catalog or check the articles section for related context.